ATXI

Avenue Therapeutics, Inc. Common Stock

Delisted

ATXI was delisted on the 18th of March, 2025.

14 hedge funds and large institutions have $520K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$306K 264,000 +264,000 New
Bank of New York Mellon
2
Bank of New York Mellon
New York
$61.9K 53,363 +53,363 New
Qube Research & Technologies (QRT)
3
Qube Research & Technologies (QRT)
United Kingdom
$55K 47,400 +47,400 New
VF
4
Virtu Financial
New York
$38K 32,570 +32,570 New
Citigroup
5
Citigroup
New York
$20.1K 17,321 +16,811 +3,296%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$13K 11,534 +11,534 New
BCM
7
Bayesian Capital Management
New York
$12.8K 11,000 +11,000 New
Wells Fargo
8
Wells Fargo
California
$5.29K 4,561 +23 +0.5%
Morgan Stanley
9
Morgan Stanley
New York
$3.87K 3,332 +1,858 +126%
BlackRock
10
BlackRock
New York
$2.25K 1,941
UBS Group
11
UBS Group
Switzerland
$1.45K 1,246 +108 +9%
EL
12
EMFO LLC
Florida
$618 533
Bank of America
13
Bank of America
North Carolina
$14 12 +11 +1,100%
Citadel Advisors
14
Citadel Advisors
Florida
-35,865 Closed
Two Sigma Investments
15
Two Sigma Investments
New York
-14,342 Closed
TSS
16
Two Sigma Securities
New York
-14,159 Closed
TRCT
17
Tower Research Capital (TRC)
New York
-1,425 Closed
CFGS
18
Concourse Financial Group Securities
Alabama
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$0 55 +55 New